4//SEC Filing
OXIGENE INC 4
Accession 0001181431-13-038058
$OTLCCIK 0000908259operating
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:59 PM ET
Size
5.3 KB
Accession
0001181431-13-038058
Insider Transaction Report
Form 4
OXIGENE INCOXGN
CHAPLIN DAVID
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2013-07-01+10,060→ 10,060 totalExercise: $2.70From: 2013-07-01Exp: 2019-07-01→ Common Stock (10,060 underlying)
Footnotes (2)
- [F1]Dr. Chaplin was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options") pursuant to the OXiGENE, Inc. Amended and Restated Non-Employee Director Compensation Policy as partial payment for Board of Directors services to be provided during the last six months of 2013.
- [F2]The Stock Options were fully vested as of the grant date.
Documents
Issuer
OXIGENE INC
CIK 0000908259
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000908259
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:59 PM ET
- Size
- 5.3 KB